← Leaderboards
Qitao Ran
South Texas Veterans Health Care System
$3,440,029
Attributed
$3,440,029
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $539.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,440,029 · 3
VA$0 · 4
By mechanism
R01$2,999,589 · 2
K01$440,440 · 1
I01$0 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMouse ModelOverexpressionNeuronsAffectPathogenesisGlutathione PeroxidaseHydrogen PeroxideCognitionCellsS DiseaseIronCell DeathAblationPlayVeteransMembranePhenotypeReactive Oxygen SpeciesNerve DegenerationNeurodegenerative DisordersImpaired CognitionIn VivoOnset Of Illness
Grant awards (26)
The Hippo signaling pathway as a target of intervention for Alzheimerâs disease$528,723
R01 · FY2025 · AG · contact PI
Investigation of Ferroptosis as a Therapeutic Target for ALS$0
I01 · FY2025 · VA · contact PI
The Hippo signaling pathway as a target of intervention for Alzheimerâs disease$539,512
R01 · FY2024 · AG · contact PI
Investigation of Ferroptosis as a Therapeutic Target for ALS$0
I01 · FY2024 · VA · contact PI
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease$387,500
R01 · FY2023 · AG · contact PI
Investigation of Ferroptosis as a Therapeutic Target for ALS$0
I01 · FY2023 · VA · contact PI
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease$387,500
R01 · FY2022 · AG · contact PI
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease$386,667
R01 · FY2021 · AG · contact PI
Gpx4 and ferroptosis inhibition in retarding ALS$0
I01 · FY2021 · VA · contact PI
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease$385,000
R01 · FY2020 · AG · contact PI
Gpx4 and ferroptosis inhibition in retarding ALS$0
I01 · FY2020 · VA · contact PI
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease$384,687
R01 · FY2019 · AG · contact PI
Gpx4 and ferroptosis inhibition in retarding ALS$0
I01 · FY2019 · VA · contact PI
Gpx4 and ferroptosis inhibition in retarding ALS$0
I01 · FY2018 · VA · contact PI
Mitochondrial ROS in environmental toxin-induced AD pathogenesis$0
I01 · FY2015 · VA · contact PI
Mitochondrial ROS in environmental toxin-induced AD pathogenesis$0
I01 · FY2014 · VA · contact PI
Mitochondrial ROS in environmental toxin-induced AD pathogenesis$0
I01 · FY2013 · VA · contact PI
Mitochondrial ROS in environmental toxin-induced AD pathogenesis$0
I01 · FY2012 · VA · contact PI
The preventive and therapeutic potential of reducing mitochondrial H2O2 for AD$0
I01 · FY2011 · VA · contact PI
The preventive and therapeutic potential of reducing mitochondrial H2O2 for AD$0
I01 · FY2011 · VA · contact PI
The preventive and therapeutic potential of reducing mitochondrial H2O2 for AD$0
I01 · FY2009 · VA · contact PI
Lipid peroxidation in amyloid plaque formation$92,163
K01 · FY2007 · AG · contact PI
Lipid peroxidation in amyloid plaque formation$90,108
K01 · FY2006 · AG · contact PI
Lipid peroxidation in amyloid plaque formation$88,112
K01 · FY2005 · AG
Lipid peroxidation in amyloid plaque formation$86,163
K01 · FY2004 · AG
Lipid peroxidation in amyloid plaque formation$83,894
K01 · FY2003 · AG